Name | eletriptan |
---|---|
Synonyms |
3-{[(2R)-1-Methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole
3-{[(2R)-1-Methyl-2-pyrrolidinyl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole Eletriptan MFCD00943792 1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]- 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole |
Description | Eletriptan (UK-116044) is a highly selective and orally active serotonin 5-HT1B and 5-HT1D receptor agonist, with pKi values of 8.0 and 8.9, respectively. Eletriptan has inhibitory effects on markers of neurogenic inflammation in rats. Eletriptan can be used for researching migraine[1]. |
---|---|
Related Catalog | |
Target |
5-HT1B Receptor:8.0 (pKi) 5-HT1D Receptor:8.9 (pKi) |
In Vivo | Eletriptan (10, 30, 100, 300 and 1000 µg/kg; i.v.) reduces total carotid blood flow in anaesthetised pigs by selectively reducing carotid arteriovenous anastomotic blood flow and increasing nutrient blood flow within the carotid vascular bed[2]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 613.4±55.0 °C at 760 mmHg |
Molecular Formula | C22H26N2O2S |
Molecular Weight | 382.519 |
Flash Point | 324.8±31.5 °C |
Exact Mass | 382.171509 |
PSA | 61.55000 |
LogP | 3.08 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.634 |
Storage condition | Hygroscopic, Refrigerator, Under Inert Atmosphere |
Precursor 8 | |
---|---|
DownStream 1 | |